CVC's Cathrin Petty and Manna Tree's Ellie Rubenstein are named to PE Hub's and Buyouts' 2024 Women in Private Equity list, spotlighting female leadership in the sector. Concurrently, Blackstone is initiating a sale process for its portfolio company Precision Medicine Group (PMG), specifically targeting its contract research organization and pharmaceutical commercialization divisions, according to three sources. This dual development signals significant activity within the private equity and healthcare investment landscapes.

The awards recognize Petty and Rubenstein's roles in driving portfolio performance and strategic growth at their firms. Blackstone's move to divest PMG's specialized units reflects a potential strategic shift, focusing resources on core healthcare assets or exploring new investment directions. The sale process, expected to unfold over coming months, could attract interest from private equity firms and strategic buyers seeking exposure to specialized life sciences capabilities.

The awards and Blackstone's transaction underscore evolving dynamics in healthcare investing and gender representation within private equity leadership.